Popular, Private Equity Firms, Health Care Providers

Life Science & Healthcare Private Equity Risk: Q2 2025 Update

White & Case LLP on 8/5/2025

Private capital firms focused on investment and operations within the Life Science and Healthcare industries face complex compliance, operational, and business risks. To help clients navigate this evolving environment, White...more

Event in Review: Antitrust in Healthcare: The Good, the Bad, and the Ugly

Venable LLP on 9/17/2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely...more

Healthcare Trends & Transactions Q2 2024

Bass, Berry & Sims PLC on 7/17/2024

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more

Health Care Transactions Facing Increased Federal and State Regulatory Scrutiny

Vedder Price on 7/3/2024

Private equity investments in health care to be subject to increased oversight from federal and state regulators, including antitrust officials - Federal and state governmental regulation of health care transactions...more

Antitrust & Competition Healthcare Year in Review 2023

Goodwin on 3/12/2024

2023 saw a significant uptick in antitrust scrutiny and enforcement, particularly in the healthcare space. After much rhetoric and a setback in challenging state Certificate of Public Advantage (COPA) laws, the Federal Trade...more

Antitrust Enforcers Reaffirm Focus on Private Equity in Healthcare at Public Workshop

Holland & Knight LLP on 3/8/2024

As Holland & Knight observed previously, the Biden Administration's antitrust enforcers have trained their sights on private equity firms and their portfolio companies, including in a Sept. 21, 2023, lawsuit challenging one...more

The False Claims Act Guide: 2023 and the road ahead

Hogan Lovells on 2/14/2024

In the latest edition of our False Claims Act Guide: 2023 and the road ahead, we analyze the key developments from 2023 and discuss how the most important cases and issues are shaping FCA enforcement now and in the year to...more

[Event] 2023 J.P. Morgan Healthcare Conference - January 10th, San Francisco, CA

McDermott Will & Schulte on 1/5/2023

Come together with key decision-makers, innovators and investors from across the healthcare, life sciences and private equity (PE) industries during the year’s largest healthcare investment symposium....more

[Event] 2019 Healthcare Services Private Equity Leadership Forum - October 25th, New York, NY

McDermott Will & Schulte on 9/25/2019

Among the most active markets in private equity, the healthcare industry is ripe with opportunity for players in the healthcare services arena that can navigate the fast-paced deal environment and complex regulatory...more

[Event] 2019 European Healthcare Services Private Equity Leadership Forum - September 26th, London, United Kingdom

McDermott Will & Schulte on 9/3/2019

McDermott’s annual European Healthcare Private Equity Leadership Forum is a must-attend event for executives from top management teams, health and life sciences companies and providers, private equity, family offices,...more

Hahnemann University Hospital: Healthcare Bankruptcy Highlights the Tension When Private Equity Collides with the Public Interest

Patterson Belknap Webb & Tyler LLP on 8/27/2019

A “little bit of a crisis” was averted last week in the Chapter 11 bankruptcy case of St. Christopher’s Hospital for Children, a Philadelphia-area hospital with ties to Hahnemann University Hospital, which is also a Chapter...more

Today's Popular Updates › Private Equity Firms › Health Care Providers

"My best business intelligence, in one easy email…"